Delivery Order SPE2DR25D3301-SPE2DR26F20KV
- Not listed
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for Zymfentra 120 mg/ml pen kits, with performance completion targeted for January 21, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the vendor's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,169.04 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, a pharmaceutical product to support federal medical supply needs. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by December 17, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits under a firm fixed-price contract. The order, issued on December 31, 2025, with completion targeted for January 23, 2026, represents a non-set-aside competitive award to support federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance for this delivery order—is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $6,338.08 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zymfentra 120 mg/ml pen kits with a completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,584.52 firm fixed price delivery order on December 29, 2025, for Zymfentra 120 mg/ml pen kits, with a completion deadline of January 21, 2026. The contract was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,455.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on November 10, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,007.12 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on September 19, 2025, with completion targeted for October 10, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military...
- The Defense Logistics Agency awarded a $1,503.56 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $1,584.52 and an ultimate completion date of December 24, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of September 25, 2025. This competitive delivery order represents a firm fixed price transaction with no set-aside designation. The award was made on September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20KVDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,240.82 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with performance in Conshohocken, Pennsylvania and completion by January 29, 2026. This non-competitive delivery order was awarded on January 7, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $999,999,999.00 IDC with DLA through December 2031 that serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities and other government healthcare systems. The company's federal contract awards demonstrate consistent capability to fulfill government requirements through both competitive and non-competitive procurement mechanisms, with delivery orders typically utilizing firm fixed pricing structures across varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 1/6/26 |